Thank you, Mr. Butler.
I'll ask a series of yes-or-no questions out of concern for the time I have left.
Would you agree that entities seeking to engage in a toxicity risk assessment pursuant to CEPA for a genetically modified animal should not be able to avoid the disclosure of documents that involve public interest aspects out of concern for their commercial interests? Would you agree that the public interest ought to predominate in questions of mixed commercial and public interest when you're dealing with genetically modified animals?